{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:13:08Z","timestamp":1789654388981,"version":"4.0.1"},"reference-count":64,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T00:00:00Z","timestamp":1506297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T00:00:00Z","timestamp":1506297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2017R1C1B5016737"],"award-info":[{"award-number":["2017R1C1B5016737"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1111\/jcpt.12636","type":"journal-article","created":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T03:42:49Z","timestamp":1506397369000},"page":"661-671","source":"Crossref","is-referenced-by-count":65,"title":["Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients"],"prefix":"10.1155","volume":"42","author":[{"given":"J.","family":"Hahn","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences; College of Pharmacy; Yonsei University; Incheon Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences; College of Pharmacy; Yonsei University; Incheon Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-5907","authenticated-orcid":false,"given":"M. J.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Yonsei Institute of Pharmaceutical Sciences; College of Pharmacy; Yonsei University; Incheon Korea"},{"name":"Department of Pharmaceutical Medicine and Regulatory Science; College of Medicine and Pharmacy; Yonsei University; Incheon Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"10.1111\/jcpt.12636-BIB0001|jcpt12636-cit-0001","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jcrc.2012.02.013","article-title":"Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation","volume":"27","author":"Shekar","year":"2012","journal-title":"J Crit Care"},{"key":"10.1111\/jcpt.12636-BIB0002|jcpt12636-cit-0002","first-page":"312","article-title":"A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation","volume":"19","author":"Mousavi","year":"2011","journal-title":"Daru"},{"key":"10.1111\/jcpt.12636-BIB0003|jcpt12636-cit-0003","doi-asserted-by":"crossref","first-page":"S2224","DOI":"10.1016\/j.athoracsur.2003.09.003","article-title":"The development and use of extracorporeal membrane oxygenation in neonates","volume":"76","author":"Wolfson","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1111\/jcpt.12636-BIB0004|jcpt12636-cit-0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM197203232861204","article-title":"Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung","volume":"286","author":"Hill","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12636-BIB0005|jcpt12636-cit-0005","first-page":"80","article-title":"Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy","volume":"22","author":"Bartlett","year":"1976","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1111\/jcpt.12636-BIB0006|jcpt12636-cit-0006","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1001\/jama.2009.1535","article-title":"Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome","volume":"302","author":"Davies","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/jcpt.12636-BIB0007|jcpt12636-cit-0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MAT.0b013e3182904a52","article-title":"Extracorporeal life support organization registry report 2012","volume":"59","author":"Paden","year":"2013","journal-title":"ASAIO J"},{"key":"10.1111\/jcpt.12636-BIB0008|jcpt12636-cit-0008","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(09)61069-2","article-title":"Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial","volume":"374","author":"Peek","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/jcpt.12636-BIB0009|jcpt12636-cit-0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0885066610384061","article-title":"A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients","volume":"26","author":"Allen","year":"2011","journal-title":"J Intensive Care Med"},{"key":"10.1111\/jcpt.12636-BIB0010|jcpt12636-cit-0010","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.clinthera.2016.07.169","article-title":"Pharmacokinetics and dosing of anti-infective drugs in patients on extracorporeal membrane oxygenation: a review of the current literature","volume":"38","author":"Sherwin","year":"2016","journal-title":"Clin Ther"},{"key":"10.1111\/jcpt.12636-BIB0011|jcpt12636-cit-0011","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1128\/AAC.00102-15","article-title":"Fluconazole population pharmacokinetics and dosing for prevention and treatment of invasive Candidiasis in children supported with extracorporeal membrane oxygenation","volume":"59","author":"Watt","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12636-BIB0012|jcpt12636-cit-0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mmcr.2012.12.006","article-title":"Insufficient serum caspofungin levels in a paediatric patient on ECMO","volume":"2","author":"Koch","year":"2012","journal-title":"Med Mycol Case Rep"},{"key":"10.1111\/jcpt.12636-BIB0013|jcpt12636-cit-0013","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1097\/INF.0b013e31825d3091","article-title":"Pharmacokinetics and safety of fluconazole in young infants supported with extracorporeal membrane oxygenation","volume":"31","author":"Watt","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1111\/jcpt.12636-BIB0014|jcpt12636-cit-0014","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1128\/AAC.40.5.1139","article-title":"Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation","volume":"40","author":"Amaker","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12636-BIB0015|jcpt12636-cit-0015","first-page":"573","article-title":"Venovenous extracorporeal membrane oxygenation affects renal function","volume":"95","author":"Roy","year":"1995","journal-title":"Pediatrics"},{"key":"10.1111\/jcpt.12636-BIB0016|jcpt12636-cit-0016","doi-asserted-by":"crossref","first-page":"5868","DOI":"10.1128\/AAC.00424-11","article-title":"Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets","volume":"55","author":"Patel","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/jcpt.12636-BIB0017|jcpt12636-cit-0017","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/CCM.0b013e318241e553","article-title":"Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study","volume":"40","author":"Roberts","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1111\/jcpt.12636-BIB0018|jcpt12636-cit-0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccc.2006.02.011","article-title":"Pharmacokinetic changes in critical illness","volume":"22","author":"Boucher","year":"2006","journal-title":"Crit Care Clin"},{"key":"10.1111\/jcpt.12636-BIB0019|jcpt12636-cit-0019","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1080\/17425255.2016.1201066","article-title":"Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review","volume":"12","author":"Himebauch","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1111\/jcpt.12636-BIB0020|jcpt12636-cit-0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/00003088-200342050-00001","article-title":"Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates","volume":"42","author":"Buck","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12636-BIB0021|jcpt12636-cit-0021","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00134-010-2041-z","article-title":"Determinants of drug absorption in different ECMO circuits","volume":"36","author":"Wildschut","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1111\/jcpt.12636-BIB0022|jcpt12636-cit-0022","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/026765910001500104","article-title":"In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation","volume":"15","author":"Mulla","year":"2000","journal-title":"Perfusion"},{"key":"10.1111\/jcpt.12636-BIB0023|jcpt12636-cit-0023","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1191\/0267659105pf827oa","article-title":"Sedative clearance during extracorporeal membrane oxygenation","volume":"20","author":"Bhatt-Meht","year":"2005","journal-title":"Perfusion"},{"key":"10.1111\/jcpt.12636-BIB0024|jcpt12636-cit-0024","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s00134-007-0606-2","article-title":"Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment","volume":"33","author":"Mehta","year":"2007","journal-title":"Intensive Care Med"},{"key":"10.1111\/jcpt.12636-BIB0025|jcpt12636-cit-0025","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13054-015-0891-z","article-title":"Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study","volume":"19","author":"Shekar","year":"2015","journal-title":"Crit Care"},{"key":"10.1111\/jcpt.12636-BIB0026|jcpt12636-cit-0026","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0011-3840(90)90015-W","article-title":"Extracorporeal life support for cardiopulmonary failure","volume":"27","author":"Bartlett","year":"1990","journal-title":"Curr Probl Surg"},{"key":"10.1111\/jcpt.12636-BIB0027|jcpt12636-cit-0027","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/00003246-199504000-00022","article-title":"Effect of extracorporeal membrane oxygenation flow on pulmonary capillary blood flow","volume":"23","author":"Vardi","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1111\/jcpt.12636-BIB0028|jcpt12636-cit-0028","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(14)70036-2","article-title":"Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions","volume":"14","author":"Roberts","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/jcpt.12636-BIB0029|jcpt12636-cit-0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.10.018","article-title":"Single- and multiple-dose pharmacokinetics of ethambutol and rifampicin in a tuberculosis patient with acute respiratory distress syndrome undergoing extended daily dialysis and ECMO treatment","volume":"42","author":"Strunk","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1111\/jcpt.12636-BIB0030|jcpt12636-cit-0030","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s13054-014-0565-2","article-title":"The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study","volume":"18","author":"Shekar","year":"2014","journal-title":"Crit Care"},{"key":"10.1111\/jcpt.12636-BIB0031|jcpt12636-cit-0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/FTD.0b013e318248672c","article-title":"Impact of extracorporeal membrane oxygenation and continuous venovenous hemodiafiltration on the pharmacokinetics of oseltamivir carboxylate in critically ill patients with pandemic (H1N1) influenza","volume":"34","author":"Lemaitre","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1111\/jcpt.12636-BIB0032|jcpt12636-cit-0032","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0169-409X(03)00030-9","article-title":"Pharmacokinetics in the newborn","volume":"55","author":"Alcorn","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1111\/jcpt.12636-BIB0033|jcpt12636-cit-0033","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/pharmaceutics3010053","article-title":"Factors and mechanisms for pharmacokinetic differences between pediatric population and adults","volume":"3","author":"Fernandez","year":"2011","journal-title":"Pharmaceutics"},{"key":"10.1111\/jcpt.12636-BIB0034|jcpt12636-cit-0034","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: ontogeny and drug disposition","volume":"37","author":"Wildt","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12636-BIB0035|jcpt12636-cit-0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1111\/jcpt.12636-BIB0036|jcpt12636-cit-0036","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ndt\/gfs398","article-title":"Renal function and survival in 200 patients undergoing ECMO therapy","volume":"28","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/jcpt.12636-BIB0037|jcpt12636-cit-0037","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/j.1875-9114.1998.tb03938.x","article-title":"Vancomycin pharmacokinetics in neonates receiving extracorporeal membrane oxygenation","volume":"18","author":"Buck","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12636-BIB0038|jcpt12636-cit-0038","doi-asserted-by":"crossref","first-page":"e0141016","DOI":"10.1371\/journal.pone.0141016","article-title":"Trough concentrations of vancomycin in patients undergoing extracorporeal membrane oxygenation","volume":"10","author":"Park","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12636-BIB0039|jcpt12636-cit-0039","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s13054-014-0632-8","article-title":"Vancomycin population pharmacokinetics during extracorporeal membrane oxygenation therapy: a matched cohort study","volume":"18","author":"Donadello","year":"2014","journal-title":"Crit Care"},{"key":"10.1111\/jcpt.12636-BIB0040|jcpt12636-cit-0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jfma.2015.05.017","article-title":"Pharmacokinetics of vancomycin in adults receiving extracorporeal membrane oxygenation","volume":"115","author":"Wu","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/jcpt.12636-BIB0041|jcpt12636-cit-0041","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2014.11.005","article-title":"beta-Lactam pharmacokinetics during extracorporeal membrane oxygenation therapy: a case-control study","volume":"45","author":"Donadello","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/jcpt.12636-BIB0042|jcpt12636-cit-0042","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1002\/phar.1476","article-title":"Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support","volume":"34","author":"Cies","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12636-BIB0043|jcpt12636-cit-0043","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13054-015-0953-2","article-title":"Meropenem therapy in extracorporeal membrane oxygenation patients: an ongoing pharmacokinetic challenge","volume":"19","author":"Honore","year":"2015","journal-title":"Crit Care"},{"key":"10.1111\/jcpt.12636-BIB0044|jcpt12636-cit-0044","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/jac\/dks435","article-title":"Research letters: altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern?","volume":"68","author":"Shekar","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12636-BIB0045|jcpt12636-cit-0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/tid.12327","article-title":"Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation","volume":"17","author":"Welsch","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1111\/jcpt.12636-BIB0046|jcpt12636-cit-0046","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1097\/01.CCM.0000168206.59873.80","article-title":"Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia","volume":"33","author":"Boselli","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1111\/jcpt.12636-BIB0047|jcpt12636-cit-0047","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijantimicag.2013.01.016","article-title":"Letters to the Editor: Pharmacokinetics of linezolid during extracorporeal membrane oxygenation","volume":"41","author":"De Rosa","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1111\/jcpt.12636-BIB0048|jcpt12636-cit-0048","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00134-009-1730-y","article-title":"Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia","volume":"36","author":"Martin-Loeches","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1111\/jcpt.12636-BIB0049|jcpt12636-cit-0049","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1060028015612105","article-title":"Azithromycin pharmacokinetics in adults with acute respiratory distress syndrome undergoing treatment with extracorporeal-membrane oxygenation","volume":"50","author":"Turner","year":"2016","journal-title":"Ann Pharmacother"},{"key":"10.1111\/jcpt.12636-BIB0050|jcpt12636-cit-0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40262-016-0428-x","article-title":"Amikacin in critically ill patients: a review of population pharmacokinetic studies","volume":"56","author":"Marsot","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12636-BIB0051|jcpt12636-cit-0051","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s00134-016-4267-x","article-title":"Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study","volume":"42","author":"Gelisse","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1111\/jcpt.12636-BIB0052|jcpt12636-cit-0052","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/jcpt.12636-BIB0053|jcpt12636-cit-0053","first-page":"173","article-title":"The pharmacokinetics of oseltamivir and oseltamivir carboxylate in a critically ill pediatric patient receiving extracorporeal membrane oxygenation and continuous venovenous hemodialysis","volume":"17","author":"Eyler","year":"2012","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1111\/jcpt.12636-BIB0054|jcpt12636-cit-0054","doi-asserted-by":"crossref","first-page":"e10938","DOI":"10.1371\/journal.pone.0010938","article-title":"Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support","volume":"5","author":"Wildschut","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1111\/jcpt.12636-BIB0055|jcpt12636-cit-0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0310057X1304100112","article-title":"Oseltamivir pharmacokinetics in critically ill adults receiving extracorporeal membrane oxygenation support","volume":"41","author":"Mulla","year":"2013","journal-title":"Anaesth Intensive Care"},{"key":"10.1111\/jcpt.12636-BIB0056|jcpt12636-cit-0056","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/phar.1151","article-title":"Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and\/or extracorporeal membrane oxygenation","volume":"32","author":"Eyler","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1111\/jcpt.12636-BIB0057|jcpt12636-cit-0057","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00134-010-2080-5","article-title":"Supratherapeutic oseltamivir levels during continuous dialysis: an expected risk","volume":"37","author":"Eschenauer","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1111\/jcpt.12636-BIB0058|jcpt12636-cit-0058","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00003088-199937060-00003","article-title":"Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802","volume":"37","author":"He","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12636-BIB0059|jcpt12636-cit-0059","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.10.0557","article-title":"Acute respiratory distress syndrome caused by miliary tuberculosis: a multicentre survey in South Korea","volume":"15","author":"Lee","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/jcpt.12636-BIB0060|jcpt12636-cit-0060","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/MAT.0000000000000096","article-title":"Insufficient serum levels of antituberculosis agents during venovenous extracorporeal membrane oxygenation therapy for acute respiratory distress syndrome in a patient with miliary tuberculosis","volume":"60","author":"Kim","year":"2014","journal-title":"ASAIO J"},{"key":"10.1111\/jcpt.12636-BIB0061|jcpt12636-cit-0061","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/PCC.0b013e3181e28894","article-title":"Infections acquired during extracorporeal membrane oxygenation in neonates, children, and adults","volume":"12","author":"Bizzarro","year":"2011","journal-title":"Pediatr Crit Care Med"},{"key":"10.1111\/jcpt.12636-BIB0062|jcpt12636-cit-0062","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/jac\/dkp026","article-title":"Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation","volume":"63","author":"Spriet","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/jcpt.12636-BIB0063|jcpt12636-cit-0063","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2165\/00003088-200645070-00002","article-title":"Pharmacokinetic\/pharmacodynamic profile of voriconazole","volume":"45","author":"Theuretzbacher","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/jcpt.12636-BIB0064|jcpt12636-cit-0064","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2253-13-7","article-title":"The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation","volume":"13","author":"Shekar","year":"2013","journal-title":"BMC Anesthesiol"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12636\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T07:16:30Z","timestamp":1719472590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12636","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9,25]]}}}